Experience with a measles vaccine manufactured in India.
Indian Pediatr
;
1992 Jul; 29(7): 883-7
Artículo
en Inglés
| IMSEAR
| ID: sea-7098
ABSTRACT
Five hundred and twenty seven children between 7 months and 2 years of age were vaccinated with measles vaccine manufactured by the Serum Institute of India. The sero-conversion rate in children who had no antibodies previous to vaccination was 98.4% as tested in HI. Ninety per cent of children who had pre-vaccination measles antibodies showed a two-fold or more rise in HI antibodies. The side reactions of the vaccine were negligible.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Asunto principal:
Humanos
/
Vacuna Antisarampión
/
Preescolar
/
India
/
Lactante
/
Virus del Sarampión
/
Anticuerpos Antivirales
País/Región como asunto:
Asia
Idioma:
Inglés
Revista:
Indian Pediatr
Año:
1992
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS